Dr. Laura Niklason, Founder and CEO of Humacyte, discusses this promising technology and its recent deployment as humanitarian aid for repairing vascular trauma in Ukraine.
In this episode of GMO Dialogues, Robert Sepucha, CEO of InterWell health talks about how this legislation changed the trajectory of kidney disease care in the United States, and led to value-based care models of today.
Real-world evidence can complement existing research in gaining new and valuable insights that improve kidney disease care with Dr. Ficociello and Dr. Winter.
Dr. Sumit Mohan joins this episode to discuss the importance of kidney transplantation and strategies to address inequities in kidney transplantation access.
Dr. Len Usvyat, the Global Medical Office’s head of Clinical Advanced Analytics, talks about how real-world data generated by devices is used to improve the care of people living with kidney disease.
Dr. Miriam Huntley talks about improving infectious disease diagnosis and treatment, genomic sequencing, and machine learning to solve antibiotic resistance.
Dr. Philip Held talks about the 50th anniversary of this landmark legislation, and how it changed the trajectory of kidney disease care.